Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ -1.78EBIT per Share
VS
Market
Sector
Industry
History
$ 4.41Close
$ 2.58 - $ 5.4 52-Week Range
Ticker Information
Ticker
LTRNCompany Name
LANTERN PHARMA INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQLANTERN PHARMA INC - EBIT per Share Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
LTRN - EBITPS Historical data
| Date | Earning Before Interest & Taxes (EBIT) | EBIT per Share | Share Factor | Weighted Average Shares |
|---|---|---|---|---|
| 6/30/2025 | $ -19.25M | $ -1.78 | 1 | 10.78M |
| 3/31/2025 | $ -19.88M | $ -1.84 | 1 | 10.78M |
| 12/31/2024 | $ -20.78M | $ -1.93 | 1 | 10.76M |
| 9/30/2024 | $ -19.09M | $ -1.77 | 1 | 10.76M |
| 6/30/2024 | $ -17.75M | $ -1.65 | 1 | 10.76M |
| 3/31/2024 | $ -17.53M | $ -1.63 | 1 | 10.74M |
| 12/31/2023 | $ -15.96M | $ -1.47 | 1 | 10.84M |
| 9/30/2023 | $ -15.16M | $ -1.4 | 1 | 10.86M |
| 6/30/2023 | $ -14.26M | $ -1.31 | 1 | 10.86M |
| 3/31/2023 | $ -14.01M | $ -1.29 | 1 | 10.86M |
Key Performance Insights, Last 5 Years
- LANTERN PHARMA INC's latest trailing twelve months (TTM) EBITPS stands at $ 0.
- Over the past 5 years, LANTERN PHARMA INC's average EBITPS has been $ -1.4.
- The median EBITPS for LANTERN PHARMA INC during this period was $ -1.37
- LANTERN PHARMA INC reached its highest EBITPS over the past 5 years at $ -0.78.
- The lowest EBITPS recorded by LANTERN PHARMA INC in the same timeframe $ -1.93
Similar metrics to Shares WA:
- EBITDA per Share - [Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Book Value per Share - [Calculation] The amount of equity attributed to each share, calculated as [Equity] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Sales per Share - [Calculation] The amount of revenue attributed to each share, calculated as [Revenue] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Free Cash Flow per Share - [Calculation] The amount of Free Cash Flow attributed to each share, calculated as [FCF] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Operating Cash Flow per Share - [Calculation] The amount of Operating Cash Flow attributed to each share, calculated as [NCFO] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
Definition of EBIT per Share
[Calculation] The amount of earnings before interest and taxes attributed to each share, calculated as [EBIT] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].EBIT / (Shares WA * Share Factor)
(=) EBITPS EBITPS for LANTERN PHARMA INC is calculated as follows: EBIT [ $ 0 ] / (Shares WA [ 6.22M ] * Share Factor [ 1 ])
(=) EBITPS [ $ 0 ] LTRN - EBIT per Share, Last 5 years
$ -1.93
Minimum
Dec 31, 2024
$ -0.78
Maximum
Mar 31, 2021
$ -1.4
Average
$ -1.37
Median
EBITPS Benchmark AnalysisMarket
The chart above depicts the distribution of EBITPS for companies in the Total Stock Market. The average EBITPS of the companies is $ 1.17 with a standard deviation of $ 3.44.
The following table provides additional summary stats:
EBITPS in the Market:
| filtered constituents | 3.8K |
|---|---|
| min | $ -9.77 |
| max | $ 10.86 |
| average | $ 1.17 |
| median | $ 0.39 |
| std | $ 3.44 |